Target intelligence / Profile preview

Ubiquitin specific peptidase 17 like family member 28 (USP17L28)

Target
USP17L28
Molecular classification
Enzyme, Deubiquitinase, Cysteine-type peptidase
01

Overview

Ubiquitin specific peptidase 17 like family member 28 (USP17L28) encodes a deubiquitinating enzyme that removes conjugated ubiquitin from substrate proteins, regulating their stability and turnover. It is a protein-coding gene belonging to the USP17 family and contributes to important cellular mechanisms, including cell cycle progression, apoptosis, cell migration, and response to viral infection. USP17L28 is localized in the nucleolus and exhibits cysteine-type deubiquitinase activity along with RNA and hyaluronic acid binding[1][8][9]. Its functional paralog, USP17L27, shares related activities. While USP17L28 has not yet been directly linked to specific drug interactions or validated as a clinical biomarker or therapeutic target, its family members have associations with cancer and cell death regulation.

Other names
Ubiquitin carboxyl-terminal hydrolase 17-like protein 24USP17L24USP17USP17HUSP17IUSP17JUSP17KUSP17LUSP17MDeubiquitinating enzyme 17Ubiquitin thioesterase 17Ubiquitin-specific-processing protease 17
02

Biological functions

Protein deubiquitinationRegulation of epithelial cell apoptosisPositive regulation of cell cycleCell proliferationCell migrationCellular response to viral infectionRNA bindingHyaluronic acid binding
03

Disease associations

Cancer (role inferred by paralogs and family, direct associations unreported for USP17L28)Other (potential roles in apoptosis and cell cycle regulation suggest possible relevance to other proliferative or apoptotic disorders)

Beyond the preview

Go deeper on Ubiquitin specific peptidase 17 like family member 28 (USP17L28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin specific peptidase 17 like family member 28 (USP17L28).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call